Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases

To evaluate the diagnostic significance of neutrophil cytoplasmic antibodies in chronic liver diseases, we assessed the prevalence of neutrophil cytoplasmic antibodies in autoimmune liver diseases, in particular in primary sclerosing cholangitis, autoimmune chronic active hepatitis and primary biliary cirrhosis, and we also determined the specificity of perinuclear‐pattern neutrophil cytoplasmic antibodies for these autoimmune liver diseases by testing sera from patients with nonautoimmune chronic liver diseases. Neutrophil cytoplasmic antibodies were detected in 79% of sera from patients with primary sclerosing cholangitis (n = 24), in 88% of sera from patients with autoimmune chronic active hepatitis (n = 24) and in 28% of sera from patients with primary biliary cirrhosis (n = 25). The presence of neutrophil cytoplasmic antibodies in these diseases correlated significantly (p<0.008) with the presence of cirrhosis. Neutrophil cytoplasmic antibodies were not detected in nonautoimmune liver diseases. All neutrophil cytoplasmic antibody–positive sera produced a perinuclear fluorescence pattern on ethanol‐fixed granulocytes. On neutrophils fixed with paraformaldehyde, a granular cytoplasmic immunofluorescence pattern was observed, demonstrating the cytoplasmic nature of the antigen or antigens involved. Further characterization studies showed that neutrophil cytoplasmic antibodies in autoimmune liver diseases are not directed against myeloperoxidase, proteinase 3 or elastase, the neutrophil cytoplasmic antibody specificities associated with necrotizing vasculitis, glomerulonephritis or both. On Western blots neutrophil cytoplasmic antibodies in autoimmune liver diseases showed reactivity with either lactoferrin, a 67/66‐kD protein combination or a 40‐kD polypeptide. Reactivity with either of these proteins was observed in sera from patients with primary sclerosing cholangitis (38%), autoimmune chronic active hepatitis (17%) and primary biliary cirrhosis (20%). Because the same specificities have been found in neutrophil cytoplasmic antibody–positive sera from patients with inflammatory bowel disease and rheumatoid arthritis, these data suggest that these neutrophil cytoplasmic antibodies are a corollary of chronic inflammation. (HEPATOLOGY 1993;17:411–417.)

[1]  C. Kallenberg,et al.  Association of autoantibodies to myeloperoxidase with different forms of vasculitis. , 2010, Arthritis and rheumatism.

[2]  C. Kallenberg,et al.  Antineutrophil cytoplasmic antibodies: a still-growing class of autoantibodies in inflammatory disorders. , 1992, The American journal of medicine.

[3]  F. Seibold,et al.  Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis. , 1992, Gut.

[4]  M. Kamm,et al.  Anti-neutrophil antibodies in inflammatory bowel disease: prevalence and diagnostic role. , 1992, Gut.

[5]  F. Seibold,et al.  Significance and specificity of antibodies to neutrophils detected by western blotting for the serological diagnosis of primary sclerosing cholangitis , 1991, Hepatology.

[6]  S. Targan,et al.  Anti-neutrophil cytoplasmic antibodies in ulcerative colitis. Comparison with other colitides/diarrheal illnesses. , 1991, Gastroenterology.

[7]  R. Wiesner,et al.  Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis. , 1991, Gastroenterology.

[8]  J. Schölmerich,et al.  A new type of perinuclear anti-neutrophil cytoplasmic antibody (p-ANCA) in active ulcerative colitis but not in Crohn's disease. , 1990, Immunobiology.

[9]  S. Targan,et al.  A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. , 1990, The Journal of allergy and clinical immunology.

[10]  R J Falk,et al.  Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[11]  R. Falk,et al.  Reactivity of anti-neutrophil cytoplasmic autoantibodies with HL-60 cells. , 1989, Clinical immunology and immunopathology.

[12]  C. Hack,et al.  Wegener's granulomatosis autoantibodies identify a novel diisopropylfluorophosphate-binding protein in the lysosomes of normal human neutrophils. , 1989, The Journal of clinical investigation.

[13]  C. Kallenberg,et al.  Association between active Wegener's granulomatosis and anticytoplasmic antibodies. , 1989, Archives of internal medicine.

[14]  D. Jewell,et al.  Anti-neutrophil nuclear antibody in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis. , 1989, Clinical and experimental immunology.

[15]  R. Falk,et al.  Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. , 1988, The New England journal of medicine.

[16]  A. Wiik.  Granulocyte-specific antinuclear antibodies. Possible significance for the pathogenesis, clinical features and diagnosis of rheumatoid arthritis. , 1980, Allergy.

[17]  A. Wilk.  Granulocyte‐Specific Antinuclear Antibodies , 1980 .

[18]  I. Mackay,et al.  Antinuclear factors and human leucocytes: reaction with granulocytes and lymphocytes. , 1968, Australasian annals of medicine.

[19]  P. Limburg,et al.  Antineutrophil antibodies in inflammatory bowel disease recognize different antigens. , 1993, Advances in experimental medicine and biology.

[20]  R. Falk,et al.  Antineutrophil cytoplasmic autoantibodies: disease associations, molecular biology, and pathophysiology. , 1991, International review of experimental pathology.